Marina Vasiliou is President and Managing Director of Biogen France, a leading biotechnology company that pioneers innovative science in rare neurodegenerative diseases, immunology, Alzheimer’s disease and neurology. She brings over 20 years of international leadership experience across commercial, marketing, and general management roles in the pharmaceutical industry. She began her career at MSD /Merck in the United States before holding senior positions in France and globally. Marina joined Biogen in 2017 as Vice President and General Manager of Biogen Canada, before assuming leadership of Biogen France in 2021. She holds an MBA from Penn State, is a Fulbright scholar, and earned a Master’s degree in Sociology from EHESS in Paris.